Drug Information

Drug General Information
Drug ID
D0CG8S
Former ID
DIB018010
Drug Name
oxazine 89
Drug Type
Small molecular drug
Indication Diabetic nephropathy [ICD9: 250.4; ICD10:E11.21] Clinical trial [532315]
Structure
Download
2D MOL
Formula
C19H15F4N5O2
InChI
InChI=1S/C19H15F4N5O2/c1-18(7-15(19(21,22)23)30-17(25)28-18)12-6-11(3-4-13(12)20)27-16(29)14-5-2-10(8-24)9-26-14/h2-6,9,15H,7H2,1H3,(H2,25,28)(H,27,29)/t15-,18-/m0/s1
InChIKey
MELQHVBGGSKVJQ-YJBOKZPZSA-N
PubChem Compound ID
71305058
PubChem Substance ID
162164339, 163829600, 164135695, 164161476, 178103526, 240915760
Target and Pathway
Target(s) Beta-secretase Target Info Inhibitor [532315]
References
Ref 532315beta-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer's disease. J Med Chem. 2013 May 23;56(10):3980-95.
Ref 532315beta-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer's disease. J Med Chem. 2013 May 23;56(10):3980-95.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.